Table 1.
Promising strategies for pancreatic β-cell regeneration.
Cell types | Instructive strategies | Advantages | Limitations and challenges | Functioning validity (weeks) | Involved mechanisms | Refs |
---|---|---|---|---|---|---|
Pancreatic non-β-cells | ||||||
Acinar cells | Injury (PDL, PPX); Transduction of pancreatic transcription factors MafA, PDX1 and Ngn3/ NeuroD1; Administration of cytokines EGF, CNTF, nicotinamide, LIF; Peptide (GLP-1) | Similar developmental background to β-cells in vivo; Large proportion and flexible plasticity; Share quantity of transcription factors; Corresponding metabolic mechanism and hormone secretion | Low conversion rate; Weak proliferative capacity and stability; Immature morphology and biological function; The reprogramming effectiveness and efficiency with or without gene manipulation need to be improved | 2 | PI3K/Akt pathways; MAPK/STAT3 signaling pathways; Erk1/2 signaling pathways | (101, 111, 112, 113) |
Duct cells | Injury (PDL, PPX); Ectopic overexpression of MafA, PDX1 and Ngn3/ NeuroD1, Pax6 needed for human ductal reprogramming; Administration of cytokines TGFα, DNA methyltransferase inhibitor; Peptide (GLP-1, gastrin) | 5–12 | (100, 107, 114, 115) | |||
α and δ cells | Almost complete ablation of β-cells (PDL, PPX, diphtheria toxin); Overexpression of Pdx1, PAX4, MafA; Suppression of Arx; Peptides (GLP-1, GABA, artemisinin) | 4–16 | (98, 99, 102, 103, 104, 108, 109, 110) | |||
Liver cells | Ectopically overexpressing PDX1 and NeuroD1; Down-regulating the expression of HNF1α and HNF4α; Specific factors (GLP-1R, Notch inhibitors, TGF-β inhibitors) | Conveniently accessible; Sufficient source and cultivate easily; Great regeneration and conversion ability; Share common characteristics including responsiveness to glucose, and mass of specific transcription factors | Efficient viral transfection strategies accompanied with safety concerns; Exploring cytokine or chemical induced safe and effective transition is prospective | 4–8 | Wnt signaling pathway | (119, 120, 121) |
Biliary cells | Transduction of pancreatic transcription factors Pdx1, NeuroD1, Ngn3, MafA or Pdx1/VP16; Excision of Hes1 | Conveniently accessible | Limited source of cells; Transient transformation; Expand cell source and optimize reprogramming protocol need to be investigated | 3–4 | Notch signaling pathway | (122, 123, 124, 125) |
Gastrointestinal cells | ||||||
Intestinal cells | Ectopic expression of Pdx1, MafA, and Ngn3; Excision of transcription factor FoxO1; Peptide (GLP-1); ‘Small intestinal organ’ | Simple, non-invasive, easy to access; Sufficient source and cultivate easily; Great regeneration and conversion ability; Similar glucose sensitive system and secretion mechanism with islet cells | Low conversion rate | 1–3 | PI3K/Akt/FoxO1 pathways | (126, 128, 129) |
Glandular cells | Ectopic expression of Pdx1, MafA, and Ngn3; ‘Stomach mini-organs’ | 3–6 | (134, 136, 138) |